// App-Quantinova.ai

3017 : The Immune Combination Therapy of Leukemia Using Adoptive Transfer and TGF-? Blockade.

Researchers

Presenter

  • Amina Dahmani

Principal Investigators

  • Cédric Carli

  • Louis-Philippe Caron

  • Catherine Jean

  • Martin Giroux

  • Jean-Sebastien Delisle

Medical Centers

  • Hopital Maisonneuve-Rosemont Research Center CR-HMR, Hopital Maisonneuve-Rosemont, Universite de Montreal, Montreal, QC, Canada

  • Rheumatology, Hopital Maisonneuve-Rosemont and University of Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of Differentiation 44

  • Granulocyte-macrophage-colony stimulating factor

  • Interleukin-2

Drug/Treatment

  • GM-CSF

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim